<difference-title>
m |
m |
||
Ligne 1 : | Ligne 1 : | ||
− | + | Significant associations (r?=?0.12�C0.23) were observed between psychosis vulnerability and cannabis use at all assessments. Also, cannabis use at age 16 predicted psychosis vulnerability [http://www.selleckchem.com/products/BI6727-Volasertib.html Volasertib manufacturer] at age 19 (Z?=?2.6, P? mediation and moderation analyses of COMBINE study data. Eleven United States academic sites. A total of 863 patients randomized to one of four treatment groups: naltrexone (100?mg/day; [http://en.wikipedia.org/wiki/SERCA SERCA] n?=?209), the combined behavioral intervention (CBI, n?=?236), naltrexone and CBI combined (n?=?213) and placebo naltrexone (n?=?205). Percentage of days abstinent (PDA) measured between 13 and 16 weeks post-baseline. Cravings, the potential mediator/moderator, were measured at baseline, weeks 4 and 12 using the Obsessive-Compulsive Drinking Scale. Compared with placebo, naltrexone, CBI and the combination all increased PDA by an additional 6�C10 percentage points for those with high cravings (P? PDA for those with low cravings. The effects of all three treatments were mediated at least partially by cravings; craving reduction explained 48�C53% of treatment effects (P?[http://www.selleckchem.com/products/NVP-AUY922.html Luminespib manufacturer] examine whether English legislation to make virtually all indoor public places and work-places smoke-free on 1 July 2007 displaced smoking into the home and hence increased the proportion of children exposed to levels of second-hand smoke known to be detrimental to health. Repeated cross-sectional study with data from 10 annual surveys undertaken from 1996 to 2008. England. Nationally representative samples of non-smoking children aged 4�C15 years old living in private households. Salivary cotinine, parental smoking status, whether smoking is allowed within the house, socio-demographic variables. |
Version du 5 janvier 2017 à 19:53
Significant associations (r?=?0.12�C0.23) were observed between psychosis vulnerability and cannabis use at all assessments. Also, cannabis use at age 16 predicted psychosis vulnerability Volasertib manufacturer at age 19 (Z?=?2.6, P? mediation and moderation analyses of COMBINE study data. Eleven United States academic sites. A total of 863 patients randomized to one of four treatment groups: naltrexone (100?mg/day; SERCA n?=?209), the combined behavioral intervention (CBI, n?=?236), naltrexone and CBI combined (n?=?213) and placebo naltrexone (n?=?205). Percentage of days abstinent (PDA) measured between 13 and 16 weeks post-baseline. Cravings, the potential mediator/moderator, were measured at baseline, weeks 4 and 12 using the Obsessive-Compulsive Drinking Scale. Compared with placebo, naltrexone, CBI and the combination all increased PDA by an additional 6�C10 percentage points for those with high cravings (P? PDA for those with low cravings. The effects of all three treatments were mediated at least partially by cravings; craving reduction explained 48�C53% of treatment effects (P?Luminespib manufacturer examine whether English legislation to make virtually all indoor public places and work-places smoke-free on 1 July 2007 displaced smoking into the home and hence increased the proportion of children exposed to levels of second-hand smoke known to be detrimental to health. Repeated cross-sectional study with data from 10 annual surveys undertaken from 1996 to 2008. England. Nationally representative samples of non-smoking children aged 4�C15 years old living in private households. Salivary cotinine, parental smoking status, whether smoking is allowed within the house, socio-demographic variables.